The attorneys general of Florida and Texas filed a new lawsuit challenging FDA's 2000 approval of the abortion drug Mifepristone and its more recent allowance of virtual prescribing, alleging five telehealth companies violated their states' laws due to FDA's permission of telehealth prescribing.
Source